Status:
COMPLETED
mHealth-supported Telecolposcopy for Cervical Cancer Programs in Low-resource Settings: Evaluation (mIVAA)
Lead Sponsor:
Duke University
Collaborating Sponsors:
Fogarty International Center of the National Institute of Health
Conditions:
Cervical Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The central hypothesis is that use of mIVAA (mobile Inspección Visual con Ácido Acético - Spanish for Visual Inspection with Acetic Acid (VIA)) will increase the proportion of VIA positive women who c...
Detailed Description
The study will be conducted in Lima, Peru in the context of mobile units operated by La Liga for promoting cancer screening. mIVAA comprises two components: a digital imaging device and a telemedicine...
Eligibility Criteria
Inclusion
- Age 18 or older
- Patients coming to the mobile unit for cervical cancer screening
- Willing to allow use of mIVAA during screening with VIA.
- Agree to be audio recorded
Exclusion
- Currently pregnant
- History of hysterectomy
- Does not understand the study purpose and details
- Is not willing to sign an informed consent
Key Trial Info
Start Date :
January 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT04421131
Start Date
January 8 2021
End Date
June 30 2021
Last Update
October 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
La Liga Contra el Cancer-Peru
Lima, Peru